Foshati, S., Ghanizadeh, A., & Akhlaghi, M. (2022a). Extra-Virgin Olive Oil Improves Depression Symptoms Without Affecting Salivary Cortisol and Brain-Derived Neurotrophic Factor in Patients With Major Depression: A Double-Blind Randomized Controlled Trial. Journal of the Academy of Nutrition and Dietetics, 122(2), 284-297.e1. htps://doi.org/10.1016/j.jand.2021.07.016 Foshati, S., Ghanizadeh, A., & Akhlaghi, M. (2022b). Extra-Virgin Olive Oil Improves Depression Symptoms Without Affecting Salivary Cortisol and Brain-Derived Neurotrophic Factor in Patients With Major Depression: A Double-Blind Randomized Controlled Trial. Journal of the Academy of Nutrition and Dietetics, 122(2), 284-297.e1. htps://doi.org/10.1016/j.jand.2021.07.016 Francis, H. M., Stevenson, R. J., Chambers, J. R., Gupta, D., Newey, B., & Lim, C. K. (2019). A brief diet intervention can reduce symptoms of depression in young adults – A randomised controlled trial. PLoS ONE, 14(10), 1–17. htps://doi.org/10.1371/journal.pone.0222768 Jacka, F. N., O’Neil, A., Opie, R., Itsiopoulos, C., Coton, S., Mohebbi, M., Castle, D., Dash, S., Mihalopoulos, C., Chaterton, M. Lou, Brazionis, L., Dean, O. M., Hodge, A. M., & Berk, M. (2017). A randomised controlled trial of dietary improvement for adults with major depression (the “SMILES” trial). BMC Medicine, 15(1), 1–13. htps://doi.org/10.1186/s12916-017-0791-y Nagpal, R., Shively, C. A., Register, T. C., Crati, S., & Yadav, H. (2019). Gut microbiome-mediterranean diet interactions in improving host health. F1000Research, 8, 1–18. htps://doi.org/10.12688/F1000RESEARCH.18992.1 Sánchez-Villegas, A., Galbete, C., Martinez-González, M. Á., Martinez, J. A., Razquin, C., Salas-Salvadó, J., … Marti, A. (2011). The effect of the Mediterranean diet on plasma brain-derived neurotrophic factor (BDNF) levels: The PREDIMEDNAVARRA randomized trial. Nutritional Neuroscience, 14(5), 195–201. htps://doi.org/10.1179/1476830511Y.0000000011

1. Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016). The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism, 65(8), 1038-1048. 2. Sen, C. K., Khanna, S., & Roy, S. (2006). Tocotrienols: Vitamin E beyond tocopherols. Life Sciences, 78(18), 2088-2098. 3. Aggarwal, B. B., Sundaram, C., Prasad, S., & Kannappan, R. (2010). Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseases. Biochemical Pharmacology, 80(11), 1613-1631. 4. Nesaretnam, K., & Meganathan, P. (2011). Tocotrienols: Inflammation and cancer. Annals of the New York Academy of Sciences, 1229(1), 18-22. 5. Das, S., & Das, D. K. (2007). Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets, 6(3), 168-173. 6. Magosso, E., Ansari, M. A., Gopalan, Y., Shuaib, I. L., Wong, J. W., Khan, N. A. K., ... & Yuen, K. H. (2013). Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. Nutrition Journal, 12(1), 1-8. 7. Mansor, L. S., et al. (2019). Tocotrienol-Rich Vitamin E Reduces Hepatic Fibrosis and Inflammation in Patients With Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology, 17(7), 1363-1372. 8. Khanna, S., et al. (2017). Long-Term Tocotrienol Supplementation in NAFLD Patients: A 24-Month Study. Journal of Clinical Lipidology, 11(6), 1232-1241. 9. Patel, V., et al. (2020). Tocotrienols in Reducing the Risk of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease. Hepatology Communications, 4(5), 765-776.